Literature DB >> 11167673

Terbinafine-associated inhibition of dextromethorphan metabolism in Chinese subjects.

W M Cai, B Chen, S S Ling, Y D Zhang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11167673      PMCID： PMC2014426          DOI： 10.1046/j.1365-2125.2001.01322.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin.

Authors:  L Bertilsson; Y Q Lou; Y L Du; Y Liu; T Y Kuang; X M Liao; K Y Wang; J Reviriego; L Iselius; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1992-04       Impact factor: 6.875

2.  Nortriptyline intoxication induced by terbinafine.

Authors:  P H van der Kuy; P M Hooymans
Journal:  BMJ       Date:  1998-02-07

3.  High performance liquid chromatographic determination of dextromethorphan and its metabolite in human urine.

Authors:  W M Cai; B Chen; X Chu
Journal:  Yao Xue Xue Bao       Date:  1997-11

Review 4.  Pharmacogenetic phenotyping and genotyping. Present status and future potential.

Authors:  F J Gonzalez; J R Idle
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

5.  Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafine.

Authors:  S M Abdel-Rahman; K Marcucci; T Boge; R R Gotschall; G L Kearns; J S Leeder
Journal:  Drug Metab Dispos       Date:  1999-07       Impact factor: 3.922

6.  Investigation of terbinafine as a CYP2D6 inhibitor in vivo.

Authors:  S M Abdel-Rahman; R R Gotschall; R E Kauffman; J S Leeder; G L Kearns
Journal:  Clin Pharmacol Ther       Date:  1999-05       Impact factor: 6.875

7.  Dextromethorphan metabolic phenotyping in a Chinese population.

Authors:  W M Cai; B Chen; Y X Liu; X Chu
Journal:  Zhongguo Yao Li Xue Bao       Date:  1997-09

8.  Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation.

Authors:  B Schmid; J Bircher; R Preisig; A Küpfer
Journal:  Clin Pharmacol Ther       Date:  1985-12       Impact factor: 6.875
  8 in total
  1 in total

Review 1.  Addressing phenoconversion: the Achilles' heel of personalized medicine.

Authors:  Rashmi R Shah; Robert L Smith
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.